Unforeseen Severe Cardiotoxicity Associated With Daunorubicin Chemotherapy Even at a Dose Previously Thought to Be Safe: A Case Report.
1Michigan State University College of Osteopathic Medicine, East Lansing, MI 2Department of Internal Medicine, Providence-Providence Park Hospital, Southfield, MI.
Michael C Y
MCY
Juan
Ryan T
RT
Jones
Raveend C
RC
Thabolingam
D000368:Aged; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage / Q000009:adverse effects*; D006328:Cardiac Catheterization; D066126:Cardiotoxicity / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology; D002317:Cardiovascular Agents / Q000627:therapeutic use; D003630:Daunorubicin / Q000008:administration & dosage / Q000009:adverse effects*; D004359:Drug Therapy, Combination / Q000379:methods; D004452:Echocardiography; D005260:Female; D006333:Heart Failure / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy; D006801:Humans; D012509:Sarcoma / Q000188:drug therapy*; D016896:Treatment Outcome; D014594:Uterine Neoplasms / Q000188:drug therapy*
D000903:Antibiotics, Antineoplastic; D002317:Cardiovascular Agents; D003630:Daunorubicin